期刊文献+

甲状腺髓样癌冰冻误诊原因及病理分析

Causes of Frozen Section Misdiagnosis and Clinicopathologic Analysis of Medullary Thyroid Carcinoma
下载PDF
导出
摘要 目的:探讨甲状腺髓样癌(MTC)的冰冻误诊原因,提高其诊断的准确性。方法:对两例MTC的冰冻误诊原因进行临床与组织病理学分析。结果:两例MTC患者均为男性,年龄分别为50岁及52岁,肿物最大径分别为2.3 cm及2.8 cm。由于术中冰冻切片中细胞异型不明显,肿瘤界限清楚,未能做出正确诊断。常规病理及免疫组化均证实为MTC。结论:MTC术中冰冻易误诊,但采用免疫组化能够确诊。通过加强对MTC的认识,术前检测降钙素与癌胚抗原水平能提高冰冻诊断的准确性。 Objective:To explore the causes of frozen section misdiagnosis of medullary thyroid carcinoma(MTC)and improve the accuracy of its diagnosis.Method:Clinical and histopathological analysis was made on the causes of frozen section misdiagnosis in two cases of MTC.Result:Two cases of MTC were male,aged 50 and 52 years,and the maximum diameter of the tumor were 2.3 and 2.8 cm.Because the cell atypia was not obvious in the frozen section,and the tumor boundaries were clear,so the correct diagnosis could not be made.Conventional pathology and immunohistochemistry confirmed MTC.Conclusion:MTC is easy to misdiagnose in frozen section during operation,but it can be diagnosed by immunohistochemistry.By strengthening the understanding of MTC,and the levels of calcitonin and carcinoembryonic antigen can be detected before operation,and the accuracy of frozen section diagnosis can be improved.
作者 彭娜 陈涵 PENG Na;CHEN Han(The 95th Hospital of the Chinese People’s Liberation Army,Putian 351100,China;不详)
出处 《中外医学研究》 2020年第6期73-74,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 甲状腺髓样癌 冰冻诊断 误诊 Medullary thyroid carcinoma Frozen section diagnosis Misdiagnosis
  • 相关文献

参考文献8

二级参考文献65

  • 1张喜卿,张哉根,张同全,孙明祥,孙天玉.甲状腺髓样癌16例临床病理分析[J].诊断病理学杂志,2005,12(2):112-114. 被引量:6
  • 2Sherman SI. Neoplasms of the thyroid//[ M ] Hong WK,Bast Jr R C, Hair WN,Kufe DW,Pollock RE,Weichselbaum RR,Holland JF, Frei III E(eds).Cancer Medcine 81h Edition.PMPH-USA Ltd, Shehon,2010:923-932.
  • 3Balnch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology anti morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference [J]. Diagn Cytopathol, 2008,36(6):425-437.
  • 4Saggiorato E, De Pompa R, Volante M,et al. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application [J ]. Endocr Relat Cancer, 2005, 12(2):305-317.
  • 5Costa AM, Herrero A, Fresno MF,et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma [J]. Clin Endncrinol (Oxf), 2008,68(4): 618-634.
  • 6Sherman SI.Early clinical studies of novel therapies for thyroid cancers [J].Endocrinol Metab Clin North Am,2008,37(2): 511-524.
  • 7Shattuck TM, Westra WH, Ladenson PW.et al.Independent clonal origins of distinct tumor loci in multifocal papillary, thyroid carcinoma[J].N Engl J Med, 2005,352(23):2406-2412.
  • 8Giannini R, Ugolini C, Lupi C, et al.The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor fnci in multifocal papillary thyroid carcinoma[J].J Clin Endocrinol Metab,2007,92(9):3511-3516.
  • 9Boucek J, Kastner J, Skrivan J, et al.Occuh thyroid carcinoma [J ].Acta Otorhinolaryngol Ital,2009,29(6):296-304.
  • 10Papotti M, Rodriguez J, De Pompa R,et al.Galeclin-3 and HBME-I expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential [J].Mod Pathol,2005,18(4):541-546.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部